Marker Therapeutics Inc (MRKR)

[YettiM]

New here but been watching this one for awhile and did some DD.

Elevate Bio acquired Allovir (which was Viracyte) last year.

https://elevate.bio/press-release-may-22/

Allovir has the same group of people involved that developed the technology MRKR uses. Elevate Bio has been building a manufacturing center in MA that looks to be completed soon. At that point they can start manufacturing Allovir’s product which uses the exact same manufacturing process as MRKR. In MRKR most recent annual filing on 3/12 they noted: “However, in 2020 we will initiate a technology transfer process to a manufacturing facility capable of supplying commercial grade clinical products”

Also reviewing Tapimmune/MRKR original merger document SEC filing Peter Hoang originally was proposed to become the CEO of ViraCyte (Now Allovir). He declined and ended up CEO of Tapimmune which became MRKR. The merger agreement noted the following:
“In or around August 2017, ViraCyte issued approximately 1.0% of ViraCyte’s equity to Mr. Hoang in appreciation of his assistance to ViraCyte”

Elevate Bio recently raised more funding.

https://elevate.bio/press-release-march-30/

They stated in the release: “Throughout 2019, ElevateBio commenced operations of additional cell and gene therapy companies, including highly innovative AAV-based gene therapies, TCR, and CAR T cells, which will be publicly disclosed later in 2020” Seems with the same manufacturing process and people involved it could be in the realm of possibility we could see something here. Been way too quiet and last updates are over a year ago on these Baylor trials. Also why does MRKR VP of Regulatory Affairs LinkedIn page still state she works for Gilead/Kite 8 months after being hired at MRKR?